EU-Africa pharma and healthcare marketplace & matchmaking events
Ending the COVID-19 pandemic and avoiding future health crisis is of mutual interest for both Africa and the EU. Acting as Team Europe, the EU, its Member States and the European financial institutions are mobilising resources to ensure equitable access to safe, effective, quality, and affordable vaccines, therapeutics, equipment and other health products worldwide.
The Team Europe initiative on manufacturing and access to medicines, vaccines and health technologies (MAV+) in Africa is committed to involve all the important actors in this area, including the public and private sectors.
In May To support the above objective, the European Commission launched the EU-Africa pharma and healthcare marketplace and matchmaking events on pharma and healthcare, which aims to:
Build-up and strengthen the existing relationship between EU and Africa on health products production to address global health needs.
Support the research uptake, innovation and manufacturing of vaccines, therapeutics, diagnostics, equipment or other health technologies necessary to prevent and treat diseases, particularly prevalent in Africa or relevant for global threats.
Enhance the collaboration between EU and African organisations in the value chains of pharma and medical technology industry.
On 27 June the webinar on Future for EU-Africa healthcare will host EC and AU Commissioners and high-level representatives of private sector and will discuss about the future steps and opportunities regarding the EU-Africa partnership. The webinar will be followed by matchmaking meetings on June 27 and 28.
Find more details on the website: EU-Africa pharma and healthcare marketplace & matchmaking events – Info (b2match.io).
Registration for the next webinar on the 27th of June - Future for EU-Africa healthcare is open here.